Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

[1]  R. Weichselbaum,et al.  Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Secic,et al.  Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck , 2000, Cancer.

[3]  A. Trotti,et al.  Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer. , 1999, Journal of the National Cancer Institute.

[4]  G. Calais,et al.  Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma. , 1999, Journal of the National Cancer Institute.

[5]  E. Franssen,et al.  Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck. , 1999, International journal of radiation oncology, biology, physics.

[6]  E. B. Butler,et al.  Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[7]  J. Pignon,et al.  Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy? , 1999, Hematology/oncology clinics of North America.

[8]  H. Saito,et al.  Granulocyte‐colony‐stimulating factor enhances invasive potential of human head‐and‐neck‐carcinoma cell lines , 1999, International journal of cancer.

[9]  Jay S. Cooper,et al.  A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 , 1999 .

[10]  J. Widder,et al.  7 Continuous hyperfractionated accelerated radiotherapy and mitomycin C in head and neck cancer , 1999 .

[11]  J. Brown.  Gold medal award recipient , 1999 .

[12]  R. Komaki,et al.  2 Randomized prospective comparison of adjuvant mediastinal radiation (RT) with or without concurrent chemotherapy with cisplatin and etoposide (PE) for patients with completely resected 51-3N1-2M0 non-small cell lung cancer (NSCLC): US , 1999 .

[13]  Seegenschmiedt Mh.  Interdisciplinary documentation of treatment side effects in oncology : Present status and perspectives , 1998 .

[14]  K. Ang,et al.  Altered fractionation trials in head and neck cancer. , 1998, Seminars in radiation oncology.

[15]  A. Huang,et al.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. , 1998, The New England journal of medicine.

[16]  T. Wendt,et al.  Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Fujieda,et al.  Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma. , 1998, Cancer research.

[18]  T. Zhu,et al.  Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer. , 1997, International journal of radiation oncology, biology, physics.

[19]  P. Harari.  Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Weir,et al.  A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  B. Jeremic,et al.  Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  S. Rockwell,et al.  Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Dietz,et al.  47 Results of a German multicentric trial of accelerated hyperfractionated radiochemotherapy in advanced head and neck cancer , 1996 .

[24]  Cai Grau,et al.  110Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week — Preliminary report from the Dahanca 6 and 7 trial , 1996 .

[25]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[26]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer Treatment and Research.

[27]  L. Eapen,et al.  Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Weichselbaum,et al.  Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  E. Vokes,et al.  Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  S. Kaasa,et al.  Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. , 1994, Acta oncologica.

[31]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  G. Sanguineti,et al.  Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. , 1992, The New England journal of medicine.

[33]  L. Souhami,et al.  Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. , 1991, International journal of radiation oncology, biology, physics.

[34]  B W Brown,et al.  Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. , 1990, International journal of radiation oncology, biology, physics.

[35]  J. Fowler.  The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[36]  S. Rockwell,et al.  Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. , 1989, International journal of radiation oncology, biology, physics.

[37]  L J Peters,et al.  Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. , 1988, Acta oncologica.

[38]  J. M. Taylor,et al.  The hazard of accelerated tumor clonogen repopulation during radiotherapy. , 1988, Acta oncologica.

[39]  T. Pajak,et al.  Radiation therapy alone or in combination with surgery in head and neck cancer , 1985, Cancer.

[40]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[41]  R. Million,et al.  Management of Head and Neck Cancer: A Multidisciplinary Approach , 1984 .

[42]  R. Million.  Management of head and neck cancer , 1984 .